T1	Participants 97 123	group III rhabdomyosarcoma
T2	Participants 352 384	osteosarcoma and Ewing's sarcoma
T3	Participants 433 473	patients with group III rhabdomyosarcoma
T4	Participants 599 621	444 group III patients
T5	Participants 1364 1393	those with alveolar histology
T6	Participants 1786 1804	group III patients
